Placebo | Fedotozine | |
No. of patients | 131 | 140 |
Sex (M:F) | 66:65 | 66:74 |
Age (years) | ||
Mean (SD) | 41.0 (13.6) | 42.8 (14.4) |
Range | 18–74 | 18–75 |
Weight (kg) | 72.4 (12.9) | 70.0 (13.5 |
Baseline self evaluation score | ||
Overall intensity | 1.5 (0.7) | 1.6 (0.7) |
Epigastric pain | 1.2 (0.8) | 1.3 (0.8) |
Inability to finish meal | 0.7 (0.8) | 0.8 (0.8) |
Nausea | 0.6 (0.8) | 0.7 (0.8) |
Slow digestion | 1.2 (0.9) | 1.2 (0.8) |
Sensation of fullness | 1.4 (0.8) | 1.4 (0.8) |
Global score | 1.0 (0.6) | 1.1 (0.6) |
Associated symptoms | ||
Oesophageal reflux | 67.2% | 62.9% |
Irritable bowel | 74.8% | 71.4% |
Results are expressed as mean (SD).